Table 1.
Study Outcomes and Individual Participant Characteristics
| Variable | Mean±SD | r ADRRs | r ADRRc |
|---|---|---|---|
| ADRRs | 54±12.5 | ||
| ADRRc | 46±10.8 | ||
| MAGEs (mmol/L) | 9.7±2.1 | 0.88* | 0.41* |
| MAGEc (mmol/L) | 8.7±1.6 | 0.12 | 0.61* |
| |
Mean blood glucose (mmol/L) |
|
|||||
|---|---|---|---|---|---|---|---|
| Age (year)/gender | HbA1c (%) | CGM | SMBG | ADRRs | ADRRc | MAGEs (mmol/L) | MAGEc (mmol/L) |
| 7/F | 6.6 | 8.0 | 9.4 | 32 | 38 | 6.9 | 8.3 |
| 6/M | 6.8 | 10.1 | 10.2 | 58 | 45 | 10.3 | 8.7 |
| 7/M | 6.8 | 7.8 | 9.9 | 28 | 53 | 7.8 | 7.7 |
| 4/M | 7.0 | 8.8 | 10.7 | 46 | 74 | 10.0 | 8.0 |
| 6/M | 7.0 | 10.4 | 11.6 | 29 | 45 | 6.2 | 9.9 |
| 5/M | 7.1 | 9.9 | 9.3 | 41 | 32 | 6.7 | 7.7 |
| 5/F | 7.1 | 9.4 | 8.5 | 38 | 51 | 8.0 | 7.5 |
| 5/M | 7.2 | 11.8 | 11.8 | 65 | 47 | 10.3 | 9.7 |
| 6/F | 7.2 | 9.9 | 10.5 | 34 | 45 | 10.0 | 6.5 |
| 4/M | 7.4 | 8.9 | 11.1 | 51 | 51 | 9.9 | 8.8 |
| 5/F | 7.4 | 9.9 | 9.8 | 54 | 36 | 9.5 | 6.6 |
| 6/M | 7.4 | 10.1 | 12.4 | 25 | 48 | 9.5 | 4.4 |
| 6/F | 7.4 | 9.5 | 9.1 | 55 | 41 | 8.9 | 7.9 |
| 3/M | 7.5 | 9.6 | 9.2 | 43 | 58 | 9.0 | 9.7 |
| 3/F | 7.5 | 10.1 | 9.9 | 77 | 31 | 7.7 | 12.2 |
| 5/M | 7.5 | 11.0 | 11.3 | 40 | 47 | 7.7 | 8.8 |
| 5/F | 7.5 | 10.4 | 11.4 | 52 | 53 | 10.6 | 7.9 |
| 6/M | 7.5 | 10.3 | 10.3 | 36 | 52 | 7.7 | 9.0 |
| 6/F | 7.5 | 9.3 | 9.5 | 40 | 49 | 9.0 | 7.3 |
| 4/M | 7.7 | 12.4 | 9.9 | 48 | 53 | 10.2 | 11.3 |
| 5/F | 7.7 | 14.9 | 12.4 | 43 | 65 | 10.0 | 10.8 |
| 6/F | 7.8 | 10.0 | 9.0 | 20 | 54 | 6.9 | 9.4 |
| 6/F | 7.8 | 11.5 | 12.1 | 60 | 69 | 11.5 | 10.4 |
| 6/F | 7.8 | 11.8 | 12.3 | 38 | 41 | 9.3 | 7.7 |
| 5/F | 7.9 | 10.8 | 12.4 | 56 | 61 | 12.4 | 10.4 |
| 3/M | 8.0 | 15.7 | 15.0 | 60 | 45 | 11.5 | 9.2 |
| 4/M | 8.0 | 13.0 | 11.5 | 56 | 59 | 11.0 | 9.2 |
| 6/F | 8.0 | 8.3 | 10.5 | 36 | 76 | 10.3 | 7.8 |
| 3/M | 8.1 | 11.9 | 10.4 | 36 | 66 | 8.7 | 9.2 |
| 6/F | 8.1 | 11.0 | 10.9 | 61 | 50 | 11.0 | 9.0 |
| 2/M | 8.3 | 7.1 | 7.4 | 53 | 25 | 6.4 | 9.2 |
| 6/M | 8.3 | 9.0 | 13.9 | 60 | 56 | 11.6 | 11.3 |
| 6/F | 8.3 | 11.1 | 15.2 | 67 | 75 | 12.9 | 7.8 |
| 5/M | 8.4 | 13.8 | 11.4 | 56 | 69 | 12.6 | 11.8 |
| 5/M | 8.6 | 14.9 | 14.2 | 47 | 54 | 11.3 | 8.6 |
| 6/M | 8.6 | 12.3 | 13.7 | 56 | 54 | 12.4 | 10.8 |
| 6/M | 8.6 | 12.1 | 12.7 | 81 | 51 | 11.2 | 10.1 |
| 6/F | 8.7 | 10.3 | 10.9 | 56 | 49 | 9.2 | 6.3 |
| 5/M | 8.8 | 14.8 | 12.6 | 56 | 65 | 13.7 | 10.0 |
| 5/F | 8.8 | 12.1 | 12.2 | 59 | 49 | 11.9 | 8.0 |
| 6/M | 8.8 | 10.4 | 12.8 | 39 | 47 | 6.7 | 8.2 |
| 6/F | 8.9 | 11.2 | 11.8 | 54 | 63 | 12.2 | 9.4 |
| 5/M | 9.0 | 10.7 | 12.7 | 40 | 56 | 12.5 | 6.2 |
| 5/M | 9.1 | 10.9 | 9.9 | 44 | 57 | 9.0 | 9.3 |
| 5/F | 9.2 | 11.2 | 11.1 | 51 | 49 | 11.1 | 8.5 |
| 2/F | 9.3 | 11.5 | 10.2 | 42 | 30 | 7.9 | 7.0 |
| 5/M | 12.7 | 11.4 | 10.9 | 35 | 58 | 9.4 | 6.0 |
*
P<0.01.
ADRRc, average daily risk range using continuous glucose monitoring; ADRRs, average daily risk range using self-monitoring of blood glucose; CGM, continuous glucose monitoring; HbA1c, glycosylated hemoglobin A1c; MAGEc, mean amplitude of glycemic excursion using continuous glucose monitoring; MAGEs, mean amplitude of glycemic excursion using self-monitoring of blood glucose; SMBG, self-monitoring of blood glucose.